Use of discriminant analysis based on echocardiography for classification of congestive heart failure in dogs with myxomatous mitral valve disease

被引:0
|
作者
Silva, A. C. [1 ]
Muzzi, R. A. L. [1 ]
Muzzi, L. A. L. [1 ]
Ferreira, D. F. [1 ]
Oberlender, G. [1 ]
Oliveira, M. S. [1 ]
Nogueira, R. B. [1 ]
Ticle, L. B. [2 ]
机构
[1] Univ Fed Lavras, UFLA, Lavras, MG, Brazil
[2] Hosp Vaz Monteiro, Lavras, MG, Brazil
关键词
canine; cardiac disease; statistical model; vena contracta; VENA CONTRACTA AREA; DOPPLER-ECHOCARDIOGRAPHY; NATURAL-HISTORY; REGURGITATION; SEVERITY; PREDICTION; MORTALITY;
D O I
10.1590/1678-6800
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Mixomatous mitral valve disease (MMVD) is one of the most common cardiac abnormalities in dogs and humans that can lead to cardiac heart failure (CHF). Its diagnosis remains based on echocardiography and clinical signs. However, the early diagnose of MMVD can contribute to a better prognosis and avoid CHF. The aim of this study was to evaluate the clinical, radiographic and echocardiographic presence of CHF in dogs with MMVD in combination with a statistical model as a mathematical tool. For this purpose, dogs were divided into three groups (healthy; MMVD without CHF; and MMVD with CHF), according the clinical, radiographic and echocardiographic evaluation findings. Thus, linear discriminant functions were obtained by analyzing the variables weight, body surface area, aortic diameter, the ratio of the left atrium/aortic diameter, the ratio between the mitral regurgitation jet area and the left atrial area, vena contracta diameter and mitral valve proximal isovelocity surface area. Then, mathematical equations were established for each group of dogs. Statistical functions obtained in this study enabled to classify the dogs, regarding the presence of CHF with a probability of correct classification of 90.4%. Thus the statistical model demonstrated that it could be used as an auxiliary method for identifying CHF in dogs with MMVD.
引用
下载
收藏
页码:1727 / 1734
页数:8
相关论文
共 50 条
  • [21] Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease
    Franchini, A.
    Abbott, J. A.
    Tyrrell, W.
    Rosenthal, S.
    Lahmers, S.
    Menciotti, G.
    Crosara, S.
    Haggstrom, J.
    Borgarelli, M.
    JOURNAL OF VETERINARY CARDIOLOGY, 2021, 34 : 112 - 119
  • [22] Echocardiographic anatomy of the mitral valve in healthy dogs and dogs with myxomatous mitral valve disease
    Wesselowski, S.
    Borgarelli, M.
    Menciotti, G.
    Abbott, J.
    JOURNAL OF VETERINARY CARDIOLOGY, 2015, 17 (02) : 97 - 106
  • [23] Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
    Coffman, Melissa
    Guillot, Emilie
    Blondel, Thomas
    Garelli-Paar, Catherine
    Feng, Shuo
    Heartsill, Susanne
    Atkins, Clarke E.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2021, 35 (04) : 1673 - 1687
  • [24] Untargeted metabolomic profiling of dogs with myxomatous mitral valve disease and congestive heart failure shows metabolic differences associated with the presence of cardiac cachexia
    Freeman, Lisa M.
    Rush, John E.
    Karlin, Emily T.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2023, 84 (12)
  • [25] CONVENTIONAL AND TISSUE DOPPLER DERIVED INDICES IN PREDICTION OF CONGESTIVE HEART FAILURE IN CANINE MYXOMATOUS MITRAL VALVE DISEASE
    Kim, J. H.
    Park, H. M.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2013, 27 (03) : 643 - 643
  • [26] Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls
    DeProspero, Dylan J.
    Hess, Rebecka S.
    Silverstein, Deborah C.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2023, 261 (11):
  • [27] Heart Rate, Heart Rate Variability, and Arrhythmias in Dogs with Myxomatous Mitral Valve Disease
    Rasmussen, C. E.
    Falk, T.
    Zois, N. E.
    Moesgaard, S. G.
    Haggstrom, J.
    Pedersen, H. D.
    Ablad, B.
    Nilsen, H. Y.
    Olsen, L. H.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (01) : 76 - 84
  • [28] Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration
    Jung, SeungWoo
    Bohan, Amy
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2018, 79 (02) : 163 - 169
  • [29] ATRIAL FIBRILLATION IS A NEGATIVE PROGNOSTIC INDICATOR IN LARGE BREED DOGS WITH MYXOMATOUS MITRAL VALVE DEGENERATION AND CONGESTIVE HEART FAILURE.
    Jung, S. W.
    Griffiths, L. G.
    Kittleson, M. D.
    Pritchard, W. R.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (03) : 711 - 712
  • [30] Pharmacologic management of myxomatous mitral valve disease in dogs
    Atkins, Clarke E.
    Haggstrom, Jens
    JOURNAL OF VETERINARY CARDIOLOGY, 2012, 14 (01) : 165 - 184